Long-term cognitive outcomes after decompressive hemicraniectomy for right-hemisphere large middle cerebral artery ischemic stroke.

cognitive impairment decompressive hemicraniectomy ischemic stroke

Journal

European journal of neurology
ISSN: 1468-1331
Titre abrégé: Eur J Neurol
Pays: England
ID NLM: 9506311

Informations de publication

Date de publication:
30 Oct 2024
Historique:
revised: 18 08 2024
received: 03 06 2024
accepted: 09 09 2024
medline: 31 10 2024
pubmed: 31 10 2024
entrez: 31 10 2024
Statut: aheadofprint

Résumé

Decompressive hemicraniectomy (DH) improves survival and functional outcome in large middle cerebral artery (MCA) infarcts. However, long-term cognitive outcomes after DH remain underexplored. In a cohort of patients with large right-hemisphere MCA infarction undergoing DH, we assessed the rates of long-term cognitive impairment over 3-year follow-up. We prospectively evaluated consecutive patients included in the Lille Decompressive Surgery Database (May 2005-April 2022) undergoing DH according to existing guidelines for large hemisphere MCA infarction. We included patients with right-sided stroke and screened with the Mini-Mental State Examination (MMSE) in at least one of the prespecified follow-ups (3-month, 1-year, 3-year). Cognitive impairment was defined as an MMSE score < 24. We included only right-hemisphere strokes to avoid testing biases related to severe aphasia. We compared clinical and neuroimaging data in patients with and without cognitive impairment. Three hundred four patients underwent DH during the study period. Among 3-month survivors, 95 had a right-hemisphere stroke and underwent at least one cognitive screening (median age = 51 years, 56.8% men). Forty-four patients (46.3%) exhibited cognitive impairment at least once during the 3-year follow-up. Baseline characteristics did not significantly differ between patients with and without cognitive impairment. Regarding long-term temporal trends, cognitive impairment was observed in 23 of 76 (30.3%), 25 of 80 (31.3%), and 19 of 66 (28.8%) patients at 3-month, 1-year, and 3-year follow-up, respectively, and it was associated with higher rates of functional disability (all p < 0.05). The persistently high rates of cognitive impairment after DH highlight the importance of cognitive monitoring to improve the long-term management of survivors.

Sections du résumé

BACKGROUND AND PURPOSE OBJECTIVE
Decompressive hemicraniectomy (DH) improves survival and functional outcome in large middle cerebral artery (MCA) infarcts. However, long-term cognitive outcomes after DH remain underexplored. In a cohort of patients with large right-hemisphere MCA infarction undergoing DH, we assessed the rates of long-term cognitive impairment over 3-year follow-up.
METHODS METHODS
We prospectively evaluated consecutive patients included in the Lille Decompressive Surgery Database (May 2005-April 2022) undergoing DH according to existing guidelines for large hemisphere MCA infarction. We included patients with right-sided stroke and screened with the Mini-Mental State Examination (MMSE) in at least one of the prespecified follow-ups (3-month, 1-year, 3-year). Cognitive impairment was defined as an MMSE score < 24. We included only right-hemisphere strokes to avoid testing biases related to severe aphasia. We compared clinical and neuroimaging data in patients with and without cognitive impairment.
RESULTS RESULTS
Three hundred four patients underwent DH during the study period. Among 3-month survivors, 95 had a right-hemisphere stroke and underwent at least one cognitive screening (median age = 51 years, 56.8% men). Forty-four patients (46.3%) exhibited cognitive impairment at least once during the 3-year follow-up. Baseline characteristics did not significantly differ between patients with and without cognitive impairment. Regarding long-term temporal trends, cognitive impairment was observed in 23 of 76 (30.3%), 25 of 80 (31.3%), and 19 of 66 (28.8%) patients at 3-month, 1-year, and 3-year follow-up, respectively, and it was associated with higher rates of functional disability (all p < 0.05).
CONCLUSIONS CONCLUSIONS
The persistently high rates of cognitive impairment after DH highlight the importance of cognitive monitoring to improve the long-term management of survivors.

Identifiants

pubmed: 39478311
doi: 10.1111/ene.16492
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e16492

Informations de copyright

© 2024 The Author(s). European Journal of Neurology published by John Wiley & Sons Ltd on behalf of European Academy of Neurology.

Références

Lin J, Frontera JA. Decompressive hemicraniectomy for large hemispheric strokes. Stroke. 2021;52(4):1500‐1510. doi:10.1161/STROKEAHA.120.032359
Frank JI, Schumm LP, Wroblewski K, et al. Hemicraniectomy and durotomy upon deterioration from infarction‐related swelling trial: randomized pilot clinical trial. Stroke. 2014;45(3):781‐787. doi:10.1161/STROKEAHA.113.003200/-/DC1
van der Worp HB, Hofmeijer J, Jüttler E, et al. European Stroke Organisation (ESO) guidelines on the management of space‐occupying brain infarction. Eur Stroke J. 2021;6(2):NP1. doi:10.1177/23969873211014112
Powers WJ, Rabinstein AA, Ackerson T, et al. Guidelines for the early management of patients with acute ischemic stroke: 2019 update to the 2018 guidelines for the early management of acute ischemic stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association [published correction appears in Stroke]. Stroke. 2019;50(12):e344‐e418. doi:10.1161/STR.0000000000000211
Casolla B, Kyheng M, Kuchcinski G, et al. Predictors of outcome in 1‐month survivors of large middle cerebral artery infarcts treated by decompressive hemicraniectomy. J Neurol Neurosurg Psychiatry. 2020;91(5):469‐474. doi:10.1136/JNNP-2019-322280
Reinink H, Jüttler E, Hacke W, et al. Surgical decompression for space‐occupying hemispheric infarction: a systematic review and individual patient meta‐analysis of randomized clinical trials. JAMA Neurol. 2021;78(2):208‐216. doi:10.1001/JAMANEUROL.2020.3745
Synhaeve NE, Schaapsmeerders P, Arntz RM, et al. Cognitive performance and poor long‐term functional outcome after young stroke. Neurology. 2015;85(9):776‐782. doi:10.1212/WNL.0000000000001882
Stolwyk RJ, Mihaljcic T, Wong DK, Chapman JE, Rogers JM. Poststroke cognitive impairment negatively impacts activity and participation outcomes: a systematic review and meta‐analysis. Stroke. 2021;52(2):748‐760. doi:10.1161/STROKEAHA.120.032215
Schmidt H, Heinemann T, Elster J, et al. Cognition after malignant media infarction and decompressive hemicraniectomy—a retrospective observational study. BMC Neurol. 2011;11:77. doi:10.1186/1471-2377-11-77
Hofmeijer J, Kappelle LJ, Algra A, Amelink GJ, van Gijn J, van der Worp HB. Surgical decompression for space‐occupying cerebral infarction (the Hemicraniectomy After Middle Cerebral Artery Infarction With Life‐Threatening Edema Trial [HAMLET]): a multicentre, open, randomised trial. Lancet Neurol. 2009;8(4):326‐333. doi:10.1016/S1474-4422(09)70047-X
Hofmeijer J, van der Worp HB, Kappelle LJ, Amelink GJ, Algra A, van Zandvoort MJE. Cognitive outcome of survivors of space‐occupying hemispheric infarction. J Neurol. 2013;260(5):1396‐1403. doi:10.1007/S00415-012-6810-1/METRICS
Jüttler E, Unterberg A, Woitzik J, et al. Hemicraniectomy in older patients with extensive middle‐cerebral‐artery stroke. N Engl J Med. 2014;370(12):1091‐1100. doi:10.1056/NEJMoa1311367
Lucas C, Thines L, Dumont F, et al. Decompressive surgery for malignant middle cerebral artery infarcts: the results of randomized trials can be reproduced in daily practice. Eur Neurol. 2012;68(3):145‐149. doi:10.1159/000337454
Van Swieten JC, Koudstaal PJ, Visser MC, Schouten H, Van Gijn J. Interobserver agreement for the assessment of handicap in stroke patients. Stroke. 1988;19:604‐607. doi:10.1161/01.STR.19.5.604
Kothari RU, Brott T, Broderick JP, et al. The ABCs of measuring intracerebral hemorrhage volumes. Stroke. 1996;27(8):1304‐1305. doi:10.1161/01.STR.27.8.1304
Vogt G, Laage R, Shuaib A, Schneider A. Initial lesion volume is an independent predictor of clinical stroke outcome at Day 90. Stroke. 2012;43(5):1266‐1272. doi:10.1161/STROKEAHA.111.646570
Von Kummer R, Broderick JP, Campbell BCV, et al. The Heidelberg bleeding classification: classification of bleeding events after ischemic stroke and reperfusion therapy. Stroke. 2015;46(10):2981‐2986. doi:10.1161/STROKEAHA.115.010049
Vahedi K, Hofmeijer J, Juettler E, et al. Early decompressive surgery in malignant infarction of the middle cerebral artery: a pooled analysis of three randomised controlled trials. Lancet Neurol. 2007;6(3):215‐222. doi:10.1016/S1474-4422(07)70036-4
Jüttler E, Schwab S, Schmiedek P, et al. Decompressive surgery for the treatment of malignant infarction of the middle cerebral artery (DESTINY). Stroke. 2007;38(9):2518‐2525. doi:10.1161/STROKEAHA.107.485649
Folstein MF, Folstein SE, McHugh PR. “Mini‐mental state.” A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975;12(3):189‐198. doi:10.1016/0022-3956(75)90026-6
Creavin ST, Wisniewski S, Noel‐Storr AH, et al. Mini‐mental state examination (MMSE) for the detection of dementia in clinically unevaluated people aged 65 and over in community and primary care populations. Cochrane Database Syst Rev. 2016;2016(1):CD011145. doi:10.1002/14651858.CD011145.PUB2
Mitchell AJ. A meta‐analysis of the accuracy of the mini‐mental state examination in the detection of dementia and mild cognitive impairment. J Psychiatr Res. 2009;43(4):411‐431. doi:10.1016/J.JPSYCHIRES.2008.04.014
Bour A, Rasquin S, Boreas A, Limburg M, Verhey F. How predictive is the MMSE for cognitive performance after stroke? J Neurol. 2010;257(4):630‐637. doi:10.1007/S00415-009-5387-9
Demeyere N. Acute post‐stroke screening for a cognitive care pathway. Lancet Healthy Longev. 2024;5(1):e4‐e5. doi:10.1016/S2666-7568(23)00257-X
Cohen J. A power primer. Psychol Bull. 1992;112(1):155‐159. doi:10.1037//0033-2909.112.1.155
Abzhandadze T, Buvarp D, Lundgren‐Nilsson Å, Sunnerhagen KS. Barriers to cognitive screening in acute stroke units. Sci Rep. 2021;11(1):19621. doi:10.1038/s41598-021-98853-5
Barnay JL, Wauquiez G, Bonnin‐Koang HY, et al. Feasibility of the cognitive assessment scale for stroke patients (CASP) vs. MMSE and MoCA in aphasic left hemispheric stroke patients. Ann Phys Rehabil Med. 2014;57(6):422‐435. doi:10.1016/j.rehab.2014.05.010
Pasi M, Salvadori E, Poggesi A, Inzitari D, Pantoni L. Factors predicting the Montreal cognitive assessment (MoCA) applicability and performances in a stroke unit. J Neurol. 2013;260(6):1518‐1526. doi:10.1007/S00415-012-6819-5/METRICS
Pendlebury ST, Rothwell PM. Incidence and prevalence of dementia associated with transient ischaemic attack and stroke: analysis of the population‐based Oxford vascular study. Lancet Neurol. 2019;18(3):248‐258. doi:10.1016/S1474-4422(18)30442-3
Umarova RM, Gallucci L, Hakim A, Wiest R, Fischer U, Arnold M. Adaptation of the concept of brain Reserve for the Prediction of stroke outcome: proxies, neural mechanisms, and significance for research. Brain Sci. 2024;14(1):77. doi:10.3390/BRAINSCI14010077
Brown DA, Wijdicks EFM. Decompressive craniectomy in acute brain injury. Handb Clin Neurol. 2017;140:299‐318. doi:10.1016/B978-0-444-63600-3.00016-7
Benaim C, Barnay JL, Wauquiez G, et al. The Cognitive Assessment Scale for Stroke Patients (CASP) vs. MMSE and MoCA in non‐aphasic hemispheric stroke patients. Ann Phys Rehabil Med. 2015;58(2):78‐85. doi:10.1016/J.REHAB.2014.12.001
Milosevich ET, Moore MJ, Pendlebury ST, Demeyere N. Domain‐specific cognitive impairment 6 months after stroke: the value of early cognitive screening. Int J Stroke. 2023;9(3):331‐341. doi:10.1177/17474930231205787

Auteurs

Giuseppe Scopelliti (G)

Université Lille, Inserm, CHU Lille, U1172 - LilNCog - Lille Neuroscience & Cognition, Lille, France.
Neurology Unit, Luigi Sacco University Hospital, Milan, Italy.

Hilde Henon (H)

Université Lille, Inserm, CHU Lille, U1172 - LilNCog - Lille Neuroscience & Cognition, Lille, France.

Olivier Masheka-Cishesa (O)

Université Lille, Inserm, CHU Lille, U1172 - LilNCog - Lille Neuroscience & Cognition, Lille, France.
Department of Neurology, CH Dunkirk, Dunkirk, France.

Julien Labreuche (J)

Department of Biostatistics, CHU Lille, Lille, France.

Gregory Kuchcinski (G)

Department of Neuroradiology, Université Lille, Inserm, CHU Lille, U1172 - LilNCog - Lille Neuroscience & Cognition, Lille, France.

Rabih Aboukais (R)

Department of Neurosurgery, Univ. Lille, Inserm U1189, CHU Lille, Lille, France.

Charlotte Cordonnier (C)

Université Lille, Inserm, CHU Lille, U1172 - LilNCog - Lille Neuroscience & Cognition, Lille, France.

Barbara Casolla (B)

Université Cote d'Azur UR2CA-URRIS, Unité Neurovasculaire, CHU Hôpital Pasteur 2, Nice, France.

Classifications MeSH